Development and Validation of a Scale to Measure Intimate Partner Violence Among Transgender and Gender Diverse Populations: Protocol for a Linear Three-Phase Study (Project Empower)

被引:5
作者
Stephenson, Rob [1 ,2 ]
Todd, Kieran [1 ]
Gamarel, Kristi E. [1 ,3 ]
Peitzmeier, Sarah [1 ,2 ]
机构
[1] Univ Michigan, Ctr Sexual & Hlth Dispar, 500 S State St, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Nursing, 500 S State St, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI USA
来源
JMIR RESEARCH PROTOCOLS | 2020年 / 9卷 / 11期
关键词
intimate partner violence; transgender; scale; MENTAL-HEALTH; SUBSTANCE USE; PSYCHOMETRIC PROPERTIES; MINORITY STRESS; WOMEN; SAMPLE; RISK; CARE; DISCRIMINATION; DEPRESSION;
D O I
10.2196/23819
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Intimate partner violence (IPV) is approximately twice as prevalent among transgender and gender diverse individuals (those whose current gender identity does not match their sex assigned at birth) than among cisgender individuals (those whose gender aligns with their sex assigned at birth). However, most existing scales measuring IPV are not validated among transgender and gender diverse populations and do not consider the unique forms of IPV experienced by transgender and gender diverse individuals. Objective: This paper describes the protocol for Project Empower, a study that seeks to develop and validate a new scale to measure IPV as experienced by transgender and gender diverse adults. A new scale is necessary to improve the accuracy of IPV measurement among transgender and gender diverse populations and may inform the current tools used to screen and link to services for transgender and gender diverse adults who experience or perpetrate IPV. Methods: The proposed new scale will be developed by a linear three-phase process. In Phase I, we will recruit a maximum of 110 transgender and gender diverse participants to participate in in-depth interviews and focus groups. Phase I will collect qualitative data on the experiences of IPV among transgender and gender individuals. After generating scale items from the qualitative data in Phase I, Phase II will conduct up to 10 cognitive interviews to examine understanding of scale items and refine wording. Phase III will then conduct a survey with an online recruited sample of 700 transgender and gender diverse individuals to validate the scale using factor analysis and examine the prevalence, antecedents, and linked health outcomes of IPV. This study will generate the first comprehensive IPV scale including trans-specific IPV tactics that has undergone robust mixed-methods validation for use in transgender and gender diverse populations, regardless of sex assigned at birth. Results: Project Empower launched in August 2019, with Phases I and II expected to be complete by late 2020. Phase III (survey of 700 transgender individuals) is expected to be launched in January 2021. Conclusions: A scale that more accurately captures the forms of IPV experienced by transgender and gender diverse people not only has the potential to lead to more accurate measurements of prevalence but also can identify unique forms of violence that may form the basis of IPV prevention interventions. Additionally, identifying the forms of IPV experienced by transgender and gender diverse people has the potential to lead to the refinement of clinical screening tools used to identify and refer those who experience and perpetrate violence in clinical settings.
引用
收藏
页数:12
相关论文
共 84 条
  • [11] Stigma, Mental Health, and Resilience in an Online Sample of the US Transgender Population
    Bockting, Walter O.
    Miner, Michael H.
    Romine, Rebecca E. Swinburne
    Hamilton, Autumn
    Coleman, Eli
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2013, 103 (05) : 943 - 951
  • [12] The perceived ethnic discrimination questionnaire: Development and preliminary validation of a community version
    Brondolo, E
    Kelly, KP
    Coakley, V
    Gordon, T
    Thompson, S
    Levy, E
    Cassells, A
    Tobin, JN
    Sweeney, M
    Contrada, RJ
    [J]. JOURNAL OF APPLIED SOCIAL PSYCHOLOGY, 2005, 35 (02) : 335 - 365
  • [13] Anxiety and Depression in Transgender Individuals: The Roles of Transition Status, Loss, Social Support, and Coping
    Budge, Stephanie L.
    Adelson, Jill L.
    Howard, Kimberly A. S.
    [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2013, 81 (03) : 545 - 557
  • [14] The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008
    Cella, David
    Riley, William
    Stone, Arthur
    Rothrock, Nan
    Reeve, Bryce
    Yount, Susan
    Amtmann, Dagmar
    Bode, Rita
    Buysse, Daniel
    Choi, Seung
    Cook, Karon
    DeVellis, Robert
    DeWalt, Darren
    Fries, James F.
    Gershon, Richard
    Hahn, Elizabeth A.
    Lai, Jin-Shei
    Pilkonis, Paul
    Revicki, Dennis
    Rose, Matthias
    Weinfurt, Kevin
    Hays, Ron
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2010, 63 (11) : 1179 - 1194
  • [15] Centers for Disease Control and Prevention, 2017, HIV TRANSG PEOPL
  • [16] Initial psychometric properties of the everyday discrimination scale in black adolescents
    Clark, R
    Coleman, AP
    Novak, JD
    [J]. JOURNAL OF ADOLESCENCE, 2004, 27 (03) : 363 - 368
  • [17] Attempted suicide among transgender persons: The influence of gender-based discrimination and victimization
    Clements-Nolle, Kristen
    Marx, Rani
    Katz, Mitchell
    [J]. JOURNAL OF HOMOSEXUALITY, 2006, 51 (03) : 53 - 69
  • [18] Measures of ethnicity-related stress: Psychometric properties, ethnic group differences, and associations with well-being
    Contrada, RJ
    Ashmore, RD
    Gary, ML
    Coups, E
    Egeth, JD
    Sewell, A
    Ewell, K
    Goyal, TM
    [J]. JOURNAL OF APPLIED SOCIAL PSYCHOLOGY, 2001, 31 (09) : 1775 - 1820
  • [19] Cudeck R., 2000, Handbook of Applied Multivariate Statistics and Mathematical Modeling
  • [20] THE BRIEF SYMPTOM INVENTORY - AN INTRODUCTORY REPORT
    DEROGATIS, LR
    MELISARATOS, N
    [J]. PSYCHOLOGICAL MEDICINE, 1983, 13 (03) : 595 - 605